1. A model‐based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar. (20th November 2013) Authors: Stringer, Frances; DeJongh, Joost; Scott, Graham; Danhof, Meindert Journal: Journal of clinical pharmacology Issue: Volume 54:Number 4(2014:Apr.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the Impact of UGT Polymorphism on the Pharmacokinetics and Pharmacodynamics of the Novel PPAR Agonist Sipoglitazar. (24th January 2013) Authors: Stringer, Frances; Ploeger, Bart A.; Jongh, Joost De; Scott, Graham; Urquhart, Richard; Karim, Aziz; Danhof, Meindert Journal: Journal of clinical pharmacology Issue: Volume 53:Number 3(2013:Mar.) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗